| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.92B | +11.8% |
| Cost of Revenue | $661.0M | +7.0% |
| Gross Profit | $2.26B | +13.4% |
| R&D Expense | $639.0M | -0.5% |
| SG&A Expense | $448.0M | +0.0% |
| Operating Income | $149.0M | +301.4% |
| Pre-tax Income | $255.0M | +454.3% |
| Income Tax | $20.0M | +11.1% |
| Net Income | $235.0M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $858.0M | +109.8% |
| Accounts Receivable | $687.0M | +10.6% |
| Current Assets | $3.64B | +6.7% |
| Total Assets | $9.71B | +2.9% |
| Current Liabilities | $2.55B | +1.2% |
| Total Liabilities | $2.71B | -10.6% |
| Stockholders' Equity | $7.00B | +9.3% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $884.0M | +17.9% |
| Capital Expenditures | $9.0M | +12.5% |
| Investing Cash Flow | $271.0M | +186.3% |
| Financing Cash Flow | -$720.0M | -100.6% |
| Free Cash Flow | $875.0M | +17.9% |
| +739.3% |
| EPS (Basic) | $1.33 | +731.3% |
| EPS (Diluted) | $1.31 | +2083.3% |